English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 23 January 2012, 09:00 HKT/SGT
Share:
    

Source: Pharma Regulatory Affairs
National Agency of Drug and Food Control, Indonesia Newly Confirmed Present at 2nd Annual Pharma Regulatory Affairs Asia

SINGAPORE, Jan 23, 2012 - (ACN Newswire) - "Asia regulations keep on changing, in particular in all the established countries like China and Japan. Another change is that many countries don't have regulations at the moment but they are going to have new regulations (e.g. drug-medical device combined product) coming, so they will uniquely register in their country very soon. In the past, you didn't need it. An example of this is India, Hong Kong, Singapore, Malaysia, etc. So there will be two major dynamics that I think companies need to be aware of," said Jack Wong, Regulatory Affairs Director, Johnson and Johnson Medical.

Indeed, like what Jack has mentioned, ensuring regulatory compliance has become one of the biggest challenges for products development in Asia.

Jack Wong will be speaking at the 2nd Annual Pharma Regulatory Affairs Asia conference, which will take place on 25-26 April 2012 in Singapore.

In China, what's the impact of the healthcare system reform on pharma companies?

In Korea, what's the impact of recently IND Regulation changes and what's the next step of regulation updates?

In Vietnam, what is the regulation framework for drug registration and product commercialisation?

In Indonesia, what are the new regulations related to pre-market evaluation?

The 2nd Annual Pharma Regulatory Affairs Asia conference will feature speakers from Thailand FDA, National Agency of Drug and Food Control, Indonesia, DIA, APEC Harmonization Centre, Novartis, AstraZeneca, Johnson & Johnson among the others, and will discuss pharma regulation updates and regulatory compliance in China, India, Korea, Thailand, Vietnam, Indonesia and Philippines.

Drop an email to enquiry@iqpc.com.sg to register for the conference or visit www.pharmaregulatoryaffairsasia.com for the full list of speakers and topics that will be covered at the 2nd Annual Pharma Regulatory Affairs Asia.

Contact:
Bryan Camoens
IQPC Worldwide
Tel: +65-67229406
Email: bryan.camoens@iqpc.com.sg


Topic: Press release summary
Source: Pharma Regulatory Affairs

Sectors: Trade Shows, BioTech
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
China General Education Announces 2026 Interim Results  
Apr 29, 2026 21:54 HKT/SGT
Adyton Resources Commences Trading on the OTCQB and Engages Market Maker  
Apr 29, 2026 19:29 HKT/SGT
Hong Kong International Licensing Show and Asian Licensing Conference conclude successfully  
Apr 29, 2026 17:58 HKT/SGT
Xiao Noodles Posts Maiden Annual Results: Revenue and Net Profit Jump in 2025 as ESG Efforts Drive Long-Term Value  
Apr 29, 2026 15:08 HKT/SGT
The Fifth International Healthcare Week set for next month, to highlight Hong Kong's position as medical technology and investment hub  
Apr 29, 2026 12:37 HKT/SGT
CTF Life Title Sponsors 'Fencing Plus' Training Programme 2026 Organised by Kai Tak Sports Initiative  
Apr 29, 2026 11:07 HKT/SGT
Global Nurse Migration Patterns Shift as Europe, Southeast Asia Absorb Growing Share of International Nurses  
Apr 28, 2026 22:00 HKT/SGT
Tenstorrent Enables AI At Scale with Industry-Leading Performance Deployed on Novel Networked AI Architecture  
Apr 28, 2026 21:00 HKT/SGT
TANAKA to Showcase Advanced Semiconductor Materials and Circular Economy Initiatives at SEMICON Southeast Asia 2026  
Tuesday, April 28, 2026 8:00:00 PM
HKTDC's response to Hong Kong's export figures for March  
Apr 28, 2026 19:23 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575